Skip to main content

Animations

MJFF Publications

5661 - 5670 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2022
  • 2023
  • 2018
  • 2021
  • 2020
  • 2023
  • 2020
  • 2023
  • Summary Details
    OPEN
    Title: Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaa010
    Citation Count: 24
  • Summary Details
    RESTRICTED
    Title: Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2020.117157
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s disease
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2022.102733
    Citation Count: 6
  • Summary Details
    OPEN
    Title: α-synuclein seed amplification in Parkinson‘s disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00374-5
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Large-scale validation of miRNAs by disease association, evolutionary conservation and pathway activity
    Journal Name: RNA Biology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15476286.2018.1559689
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13021
    Citation Count: 0
  • Summary Details
    OPEN
    Title: USP8 Down-Regulation Promotes Parkin-Independent Mitophagy in the Drosophila Brain and in Human Neurons
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells12081143
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Deep Brain Stimulation of the Subthalamic, Accumbens, or Caudate Nuclei for Patients With Severe Obsessive-Compulsive Disorder: A Randomized Crossover Controlled Study
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.07.013
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18443
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.